ArticleBiology methods & protocols2024
A new method for quantifying glyoxalase II activity in biological samples.
Article in Biology methods & protocols, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Glyoxalase II (Glo II) is a crucial enzyme in the glyoxalase system, and plays a vital role in detoxifying harmful metabolites and maintaining cellular redox balance. Dysregulation of Glo II has been linked to various health conditions, including cancer and diabetes. This study introduces a novel method using 2,4-dinitrophenylhydrazine (2,4-DNPH) to measure Glo II activity. The principle behind this approach is the formation of a colored hydrazone complex between 2,4-DNPH and pyruvate produced by the Glo II-catalyzed reaction. Glo II catalyzes the hydrolysis of S-D-lactoylglutathione (SLG), generating D-lactate and reduced glutathione (GSH). The D-lactate is then converted to pyruvate by lactate dehydrogenase, then reacting with 2,4-DNPH to form a brown-colored hydrazone product. The absorbance of this complex, measured at 430 nm, allows for the quantification of Glo II activity. The study rigorously validates the 2,4-DNPH method, demonstrating its stability, sensitivity, linearity, and resistance to interference from various biochemical substances. Compared to the existing UV method, this 2,4-DNPH-Glo II assay shows a strong correlation. The new protocol for measuring Glo II activity using 2,4-DNPH is simple, cost-effective, and accurate, making it a valuable tool for researchers and medical professionals. Its potential for widespread use in various laboratory settings, from academic research to clinical diagnostics, offers significant opportunities for future research and medical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.